Spinal surgery outcome 'inherited'RSS Feed

Spinal surgery outcome 'inherited'

The outcome of spinal surgery could be down to genetic variation, according to reports.

Researchers at the University of Pittsburgh found that the pain sensitivity gene is linked to whether surgical treatment for spinal injury is successful or not, according to HealthDay News.

The pain gene, known as catechol-O-methyltransferase (COMT), is associated with the success of treatment for lumbar degenerative disc disease, says the study, published in The Spine Journal.

Scientists studied 69 patients undergoing this surgery, performing genotype analysis for five common COMT single nucleotide polymorphisms.

They measured success by using the Oswestry Disability Index (ODI) and visual analog scale scores to categorise lower back pain.

It was found that a year after surgery, the COMT analysis was significantly linked with an improvement in ODI score.

This comes after news that primates, including humans, possess the innate ability to repair their own spinal injury.

News brought to you by Serious Law specialists in spinal injury

Posted by Paul Breen
 ADNFCR-2547-ID-800254028-ADNFCR

Back to Spinal Injury News news

New spinal implant 'to help muscle rehabilitation'

New spinal implant 'to help muscle rehabilitation'
24 November 2010
A new implant has been unveiled which could seriously improve the lives of those with traumatic spinal injury.Active Book, which is placed around spinal nerves of paralysed patients, has a number of possible...
Read More...

Spleen linked to spinal damage, say researchers

Spleen linked to spinal damage, say researchers
19 November 2010
The spleen could exacerbate the damage of a spinal cord injury, a new animal study has found.Researchers from Ohio State University looked at two groups of mice that had spinal injury and one of which...
Read More...

StemCells Inc 'plans spinal injury trial'

StemCells Inc 'plans spinal injury trial'
17 November 2010
Scientific company StemCells Inc is aiming to carry out its first clinical trial of its nerve stem cells in patients suffering from spinal cord injury, according to reports.The study, which is to take...
Read More...